newsfilter
← Latest News
GlobeNewswire·

TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation

Two clinical trial sites activatedPatient enrollment expected this quarterTrial designed to evaluate the safety and preliminary anti-tumor activity of TTX-MC138 BOSTON, Aug. 15, 2024 (GLOBE NEWSWIRE) -- TransCode